Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0002099 | HP:0002099 | Asthma | 0 | ADA CL E G H | 100 | 186 | OMIM:102700 | Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency | . | | | 75 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ADRB2 CL E G H | 154 | 286 | OMIM:600807 | Asthma, susceptibility to | . | | | 5 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | AFF4 CL E G H | 27125 | 17869 | ORPHA:444077 | Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ALG9 CL E G H | 79796 | 15672 | ORPHA:79328 | ALG9-CDG | HP:0040283 - Occasional | | | 93 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ALMS1 CL E G H | 7840 | 428 | OMIM:203800 | Alstrom syndrome | . | | | 404 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ALOX5 CL E G H | 240 | 435 | OMIM:600807 | Asthma, susceptibility to | . | | | 4 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ARL6 CL E G H | 84100 | 13210 | OMIM:209900 | Bardet-Biedl syndrome 1 | . | | | 29 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ARSL CL E G H | 415 | 719 | ORPHA:79345 | Brachytelephalangic chondrodysplasia punctata | HP:0040283 - Occasional | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | BBS1 CL E G H | 582 | 966 | OMIM:209900 | Bardet-Biedl syndrome 1 | . | | | 114 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | BCL11B CL E G H | 64919 | 13222 | OMIM:618092 | INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES | HP:0040284 - Very rare | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | C4B CL E G H | 721 | 1324 | OMIM:614379 | Complement component 4B deficiency | | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CARD10 CL E G H | 29775 | 16422 | OMIM:619632 | IMMUNODEFICIENCY 89 AND AUTOIMMUNITY; IMD89 | | | | 5 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CARD11 CL E G H | 84433 | 16393 | OMIM:617638 | Immunodeficiency 11B with atopic dermatitis | . | | | 45 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CARMIL2 CL E G H | 146206 | 27089 | OMIM:618131 | IMMUNODEFICIENCY 58; IMD58 | | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CASP8 CL E G H | 841 | 1509 | OMIM:607271 | CASPASE 8 DEFICIENCY | | | | 37 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CCDC28B CL E G H | 79140 | 28163 | OMIM:209900 | Bardet-Biedl syndrome 1 | . | | | 4 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CCL11 CL E G H | 6356 | 10610 | OMIM:600807 | Asthma, susceptibility to | . | | | 2 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CDC42BPB CL E G H | 9578 | 1738 | OMIM:619841 | | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CDKN1C CL E G H | 1028 | 1786 | ORPHA:397590 | Silver-Russell syndrome due to a point mutation | HP:0040283 - Occasional | | | 114 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CDON CL E G H | 50937 | 17104 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 200 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CDSN CL E G H | 1041 | 1802 | OMIM:270300 | Peeling skin syndrome 1 | . | | | 7 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CEACAM3 CL E G H | 1084 | 1815 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CEACAM6 CL E G H | 4680 | 1818 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CFTR CL E G H | 1080 | 1884 | OMIM:219700 | Cystic fibrosis | . | | | 1371 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CFTR CL E G H | 1080 | 1884 | ORPHA:586 | Cystic fibrosis | | | | 1371 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CLCA4 CL E G H | 22802 | 2018 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | COMT CL E G H | 1312 | 2228 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | COX4I2 CL E G H | 84701 | 16232 | OMIM:612714 | Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarialhyperostosis | . | | | 13 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CREBBP CL E G H | 1387 | 2348 | ORPHA:353281 | Rubinstein-Taybi syndrome due to 16p13.3 microdeletion | HP:0040284 - Very rare | | | 291 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | CREBBP CL E G H | 1387 | 2348 | ORPHA:353277 | Rubinstein-Taybi syndrome due to CREBBP mutations | HP:0040284 - Very rare | | | 291 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | DCTN4 CL E G H | 51164 | 15518 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | DDX41 CL E G H | 51428 | 18674 | OMIM:616871 | Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to | . | | | 23 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | DISP1 CL E G H | 84976 | 19711 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 22 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | DLL1 CL E G H | 28514 | 2908 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | DOCK8 CL E G H | 81704 | 19191 | ORPHA:217390 | Combined immunodeficiency due to DOCK8 deficiency | HP:0040281 - Very frequent | | | 217 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | DOCK8 CL E G H | 81704 | 19191 | OMIM:243700 | Hyper-Ige recurrent infection syndrome, autosomal recessive | . | | | 217 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | EDNRA CL E G H | 1909 | 3179 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ELOVL4 CL E G H | 6785 | 14415 | OMIM:614457 | Ichthyosis, spastic quadriplegia, and mental retardation | HP:0040283 - Occasional | | | 62 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | EP300 CL E G H | 2033 | 3373 | ORPHA:353284 | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | HP:0040284 - Very rare | | | 250 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ERCC2 CL E G H | 2068 | 3434 | OMIM:601675 | Trichothiodystrophy 1, photosensitive | . | | | 106 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | FCGR2A CL E G H | 2212 | 3616 | OMIM:219700 | Cystic fibrosis | . | | | 6 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | FGF8 CL E G H | 2253 | 3686 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 17 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 172 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | FLG CL E G H | 2312 | 3748 | OMIM:146700 | ICHTHYOSIS VULGARIS | | | | 63 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | FOCAD CL E G H | 54914 | 23377 | OMIM:619991 | | | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 48 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GAS1 CL E G H | 2619 | 4165 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 2 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GCLC CL E G H | 2729 | 4311 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 173 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GNB1 CL E G H | 2782 | 4396 | OMIM:616973 | Mental retardation, autosomal dominant 42 | | | | 12 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GNB2 CL E G H | 2783 | 4398 | OMIM:619503 | NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040284 - Very rare | | | 23 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 8 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040284 - Very rare | | | 8 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040284 - Very rare | | | 21 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GRHL2 CL E G H | 79977 | 2799 | OMIM:616029 | Ectodermal dysplasia/short stature syndrome | HP:0040283 - Occasional | | | 33 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | GSTM3 CL E G H | 2947 | 4635 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | HFE CL E G H | 3077 | 4886 | ORPHA:586 | Cystic fibrosis | | | | 38 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | HIRA CL E G H | 7290 | 4916 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | HLA-G CL E G H | 3135 | 4964 | OMIM:600807 | Asthma, susceptibility to | . | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | HMGA2 CL E G H | 8091 | 5009 | ORPHA:397590 | Silver-Russell syndrome due to a point mutation | HP:0040283 - Occasional | | | 2 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | HMOX1 CL E G H | 3162 | 5013 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | HNMT CL E G H | 3176 | 5028 | OMIM:600807 | Asthma, susceptibility to | . | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | IDS CL E G H | 3423 | 5389 | OMIM:309900 | Mucopolysaccharidosis, type II | . | | | 86 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | IFT172 CL E G H | 26160 | 30391 | OMIM:619471 | BARDET-BIEDL SYNDROME 20; BBS20 | | | | 48 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | IGF2 CL E G H | 3481 | 5466 | ORPHA:397590 | Silver-Russell syndrome due to a point mutation | HP:0040283 - Occasional | | | 9 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | IGHG2 CL E G H | 3501 | 5526 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | IGKC CL E G H | 3514 | 5716 | ORPHA:183675 | Recurrent infections associated with rare immunoglobulin isotypes deficiency | | | | 5 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | IL13 CL E G H | 3596 | 5973 | OMIM:600807 | Asthma, susceptibility to | . | | | 2 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | IL4R CL E G H | 3566 | 6015 | OMIM:147050 | Ige responsiveness, atopic | . | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | IL6ST CL E G H | 3572 | 6021 | OMIM:619752 | HYPER-IgE RECURRENT INFECTION SYNDROME 4A, AUTOSOMAL DOMINANT; HIES4A | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | IL6ST CL E G H | 3572 | 6021 | OMIM:619750 | IMMUNODEFICIENCY 94 WITH AUTOINFLAMMATION AND DYSMORPHIC FACIES; IMD94 | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | IPO8 CL E G H | 10526 | 9853 | OMIM:619472 | VISS syndrome | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | JAK1 CL E G H | 3716 | 6190 | OMIM:618999 | AUTOINFLAMMATION, IMMUNE DYSREGULATION, AND EOSINOPHILIA; AIIDE | | | | 12 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | JMJD1C CL E G H | 221037 | 12313 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | KCNN4 CL E G H | 3783 | 6293 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | LIFR CL E G H | 3977 | 6597 | ORPHA:3206 | Stüve-Wiedemann syndrome | HP:0040282 - Frequent | | | 144 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | LIG4 CL E G H | 3981 | 6601 | ORPHA:235 | Dubowitz syndrome | HP:0040283 - Occasional | | | 88 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | LMX1B CL E G H | 4010 | 6654 | ORPHA:495818 | 9q33.3q34.11 microdeletion syndrome | HP:0040282 - Frequent | | | 165 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | LRBA CL E G H | 987 | 1742 | OMIM:614700 | IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8 | | | | 45 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | MIA3 CL E G H | 375056 | 24008 | OMIM:619269 | ODONTOCHONDRODYSPLASIA 2 WITH HEARING LOSS AND DIABETES; ODCD2 | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | MIF CL E G H | 4282 | 7097 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | MS4A2 CL E G H | 2206 | 7316 | OMIM:147050 | Ige responsiveness, atopic | . | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | MTOR CL E G H | 2475 | 3942 | ORPHA:457485 | Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome | HP:0040283 - Occasional | | | 68 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | MUC7 CL E G H | 4589 | 7518 | OMIM:600807 | Asthma, susceptibility to | . | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | NEK9 CL E G H | 91754 | 18591 | OMIM:614262 | Arthrogryposis, perthes disease, and upward gaze palsy | . | | | 9 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | NFKB2 CL E G H | 4791 | 7795 | OMIM:615577 | Immunodeficiency, common variable, 10 | | | | 11 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | NKX2-1 CL E G H | 7080 | 11825 | ORPHA:209905 | Brain-lung-thyroid syndrome | HP:0040284 - Very rare | | | 51 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | NKX2-1 CL E G H | 7080 | 11825 | OMIM:610978 | Choreoathetosis, hypothyroidism, and neonatal respiratory distress | HP:0040283 - Occasional | | | 51 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | NOD2 CL E G H | 64127 | 5331 | OMIM:617321 | YAO SYNDROME; YAOS | | | | 187 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | NODAL CL E G H | 4838 | 7865 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 45 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | NSUN2 CL E G H | 54888 | 25994 | ORPHA:235 | Dubowitz syndrome | HP:0040283 - Occasional | | | 84 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ODAD3 CL E G H | 115948 | 28303 | OMIM:616037 | Ciliary dyskinesia, primary, 30 | . | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ODC1 CL E G H | 4953 | 8109 | ORPHA:544488 | Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | | | | 66 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | PEX5 CL E G H | 5830 | 9719 | OMIM:616716 | RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5 | | | | 99 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | PGM3 CL E G H | 5238 | 8907 | OMIM:615816 | Immunodeficiency 23 | | | | 15 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | PGM3 CL E G H | 5238 | 8907 | ORPHA:443811 | PGM3-CDG | HP:0040283 - Occasional | | | 15 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | PLA2G7 CL E G H | 7941 | 9040 | OMIM:600807 | Asthma, susceptibility to | . | | | 5 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | PLA2G7 CL E G H | 7941 | 9040 | OMIM:147050 | Ige responsiveness, atopic | . | | | 5 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | PLAG1 CL E G H | 5324 | 9045 | ORPHA:397590 | Silver-Russell syndrome due to a point mutation | HP:0040283 - Occasional | | | 3 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | PLCG2 CL E G H | 5336 | 9066 | OMIM:614468 | FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3 | | | | 21 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 665 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | PTGER2 CL E G H | 5732 | 9594 | OMIM:208550 | Asthma, nasal polyps, and aspirin intolerance | . | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | RIC1 CL E G H | 57589 | 17686 | OMIM:618761 | CATIFA SYNDROME; CATIFA | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | RREB1 CL E G H | 6239 | 10449 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SCGB3A2 CL E G H | 117156 | 18391 | OMIM:600807 | Asthma, susceptibility to | . | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SCN4A CL E G H | 6329 | 10591 | ORPHA:99735 | Myotonia permanens | HP:0040283 - Occasional | | | 263 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SDHD CL E G H | 6392 | 10683 | ORPHA:100093 | Carcinoid syndrome | HP:0040283 - Occasional | | | 129 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SEC24C CL E G H | 9632 | 10705 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SERPINA1 CL E G H | 5265 | 8941 | ORPHA:586 | Cystic fibrosis | | | | 131 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SHH CL E G H | 6469 | 10848 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 67 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SIK3 CL E G H | 23387 | 29165 | OMIM:618162 | Spondyloepimetaphyseal dysplasia, Krakow type | . | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SIX3 CL E G H | 6496 | 10889 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SLC11A1 CL E G H | 6556 | 10907 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SLC26A9 CL E G H | 115019 | 14469 | ORPHA:586 | Cystic fibrosis | | | | 5 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SLC27A4 CL E G H | 10999 | 10998 | OMIM:608649 | ICHTHYOSIS PREMATURITY SYNDROME; IPS | | | | 26 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SLC6A14 CL E G H | 11254 | 11047 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SLC9A3 CL E G H | 6550 | 11073 | ORPHA:586 | Cystic fibrosis | | | | 7 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SPINK5 CL E G H | 11005 | 15464 | ORPHA:634 | Netherton syndrome | HP:0040281 - Very frequent | | | 100 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SPINK5 CL E G H | 11005 | 15464 | OMIM:256500 | Netherton syndrome | . | | | 100 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | STX1A CL E G H | 6804 | 11433 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | STXBP1 CL E G H | 6812 | 11444 | ORPHA:495818 | 9q33.3q34.11 microdeletion syndrome | HP:0040282 - Frequent | | | 237 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | SUFU CL E G H | 51684 | 16466 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 124 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TALDO1 CL E G H | 6888 | 11559 | OMIM:606003 | Transaldolase deficiency | . | | | 34 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TBCK CL E G H | 93627 | 28261 | ORPHA:488632 | TBCK-related intellectual disability syndrome | HP:0040284 - Very rare | | | 13 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TBX1 CL E G H | 6899 | 11592 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 32 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TBX1 CL E G H | 6899 | 11592 | OMIM:188400 | Digeorge syndrome | | | | 32 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TBX21 CL E G H | 30009 | 11599 | OMIM:208550 | Asthma, nasal polyps, and aspirin intolerance | . | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TBX21 CL E G H | 30009 | 11599 | OMIM:619630 | IMMUNODEFICIENCY 88; IMD88 | | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 1 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TGFB1 CL E G H | 7040 | 11766 | ORPHA:586 | Cystic fibrosis | | | | 13 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TGFB1 CL E G H | 7040 | 11766 | OMIM:219700 | Cystic fibrosis | . | | | 13 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TNF CL E G H | 7124 | 11892 | OMIM:600807 | Asthma, susceptibility to | . | | | 7 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TRAIP CL E G H | 10293 | 30764 | OMIM:616777 | Seckel syndrome 9 | HP:0040283 - Occasional | | | 2 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | TTC26 CL E G H | 79989 | 21882 | OMIM:619534 | BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME; BRENS | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | UFD1 CL E G H | 7353 | 12520 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | UNC45A CL E G H | 55898 | 30594 | OMIM:619377 | OSTEOOTOHEPATOENTERIC SYNDROME; OOHE | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | USP7 CL E G H | 7874 | 12630 | ORPHA:500055 | 16p13.2 microdeletion syndrome | HP:0040282 - Frequent | | | 2 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | VPS51 CL E G H | 738 | 1172 | OMIM:618606 | PONTOCEREBELLAR HYPOPLASIA, TYPE 13; PCH13 | | | | | | |
HP:0002099 | HP:0002099 | Asthma | 0 | WAC CL E G H | 51322 | 17327 | ORPHA:466950 | Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation | HP:0040283 - Occasional | | | 20 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:280200 | Microform holoprosencephaly | HP:0040283 - Occasional | | | 34 | | |
HP:0002099 | HP:0002099 | Asthma | 0 | ZNF699 CL E G H | 374879 | 24750 | OMIM:619488 | DEGCAGS SYNDROME; DEGCAGS | | | | | | |
HP:0002099 | HP:0012652 | Exercise-induced asthma | 1 | CL E G H | | | | | | | | | | |
HP:0002099 | HP:0012653 | Status asthmaticus | 1 | FOCAD CL E G H | 54914 | 23377 | OMIM:619991 | | | | | 3 | | |
HP:0002099 | HP:0012042 | Aspirin-induced asthma | 1 | PTGER2 CL E G H | 5732 | 9594 | OMIM:208550 | Asthma, nasal polyps, and aspirin intolerance | . | | | 1 | | |
HP:0002099 | HP:0012042 | Aspirin-induced asthma | 1 | TBX21 CL E G H | 30009 | 11599 | OMIM:208550 | Asthma, nasal polyps, and aspirin intolerance | . | | | 1 | | |